Zhenyu He

10PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 04, 2025
Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.

Yixin Cheng, Guanyin Huang, Xuefei Liu

|Apr 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Ying Chen, Wen-Xia Li, Jia-Hua Wu

|May 20, 2022
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.

Shi-Ping Yang, Ping Zhou, Chen-Lu Lian

|Mar 20, 2021
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.

Jian Lei, Zhen-Yu He, Jun Wang

|Feb 15, 2021
Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.

Jun Wang, Shi-Ping Yang, Ping Zhou

|Jun 09, 2020
Prognostic validation and therapeutic decision-making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy.

San-Gang Wu, Jun Wang, Jian Lei

Pageof 2

Frequent Collaborators

2 joint publications

San-Gang Wu

2 joint publications

San-Gang Wu

1 joint publications

Zhenchong Xiong

1 joint publications

Jia Yuan Sun